Navigation Links
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Date:1/13/2009

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS)

GENEVA, Jan. 13 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the signature of a research, development and commercialization agreement with Apitope Technology (Bristol) Ltd., a wholly owned subsidiary of Apitope International NV. Under this agreement, Apitope has granted exclusive worldwide rights to Merck Serono to develop and commercialize Apitope's product ATX-MS-1467. This peptide therapeutic has completed an initial clinical study in patients with multiple sclerosis (MS). It is designed to induce immunological tolerance of the body's T-cells to key autoantigens involved in the pathogenesis of MS.

ATX-MS-1467 is a novel peptide-based therapeutic derived from Apitope's proprietary technology platform. Under the terms of the agreement, Apitope will receive an upfront payment and will initially be responsible for the further development of ATX-MS-1467, for which Merck Serono will fund the costs. Merck Serono will be responsible for all development activities from the beginning of Phase II clinical trials. Merck Serono will also provide committed funding to Apitope for research on other novel therapeutic peptides for the treatment of MS.

Under the terms of the agreement, Apitope is eligible to receive up to EUR 154 million in upfront, development and commercialization milestone payments, in addition to royalties on the net sales of products resulting from the collaboration.

"This partnership with Apitope strengthens our position as a leader in the field of innovative research and development in multiple sclerosis," said Bernhard Kirschbaum, Executive Vice President Research and Development at Merck Serono. "ATX-MS-1467 represents a novel, targeted approach and may have the potenti
'/>"/>

SOURCE Merck Serono
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
2. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
3. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
4. Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
5. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
6. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
7. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
8. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
9. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
10. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
11. UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Medical Solutions , ... happy to announce that our co-founder and CFO, ... Analysts’ Staffing 100 for 2014. Anderson was also ... influential people in the staffing industry,” in 2013.     ... 13th-largest healthcare staffing company in the U.S., was ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- The United ... arriving from Ebola-affected nations of West Africa land ... them for infection with the virus. In ... Johnson noted that 94 percent of air passengers ... at one of these five airports -- New ...
(Date:10/22/2014)... Washington, D.C. (PRWEB) October 22, 2014 With ... November, a national survey by the American Institutes for Research ... they know how to use health insurance, but 42 percent ... review a plan’s details before signing up for coverage. , ... literacy, with only 20 percent able to calculate correctly how ...
(Date:10/22/2014)... 2014 Losing Weight Your Body’s Way , ... you in the face, it certainly can be difficult to ... body an extra favor by doing it the healthy way? ... Instead, listen to your body, exercise regularly, and choose foods ... to losing weight; you need to exercise more and eat ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 3Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2
... PUNTA GORDA, Fla., April 25 North ... closed on Cypress,Professional Center, 25097 Olympia Avenue, ... medical office building is located near,Charlotte Regional ... practice. The building is being converted to ...
... in partnership with,others to fight the malaria epidemic, ... treatable, malaria continues to devastate communities in,tropical regions ... World Health Organization (WHO), the malaria epidemic causes,debilitating ... and kills,more than one million people each year ...
... Thoratec,Corporation (Nasdaq: THOR ), a world ... support and restore failing hearts,today announced that it ... quarter of 2008 on Thursday, May 1., ... discuss its financial,results and operating activities to all ...
... funds ... clinic., New guide to low-income dental clinics in the ... teeth, gum,disease, extractions, root canals -- the very words give us ... to regularly visit our,dentists for preventive maintenance., Upper Willamette Valley ...
... helping doctors diagnose and treat lung cancer were ... Conference jointly organized by the European Society for ... the Study of Lung Cancer (IASLC) in Geneva, ... Friday 25th April, 16:30), Israeli researchers from Rosetta ...
... AX Series Delivers MyFluVaccine Portal a Next-generation Server Load ... Balancer Platform for Web Application Delivery, ... today,announced that FFF Enterprises, the nation,s largest distributor of ... Series Advanced Traffic Manager to provide a Web application,delivery ...
Cached Medicine News:Health News:Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida 2Health News:Global Health Progress Initiative Commemorates World Malaria Day 2Health News:Global Health Progress Initiative Commemorates World Malaria Day 3Health News:Thoratec Schedules First Quarter 2008 Conference Call, Webcast 2Health News:Smiles. Made Fresh Daily 2Health News:New genetic techniques to combat lung cancer 2Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 2Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 3
(Date:10/20/2014)...  PneumRx, Inc. ( www.pneumrx.com ), a leader in ... enrollment in their RENEW Study, nearly 3 months ahead ... IDE pivotal trial for the PneumRx RePneu Coil System, ... anticipated that the study, which began enrolling subjects in ... end of 2014 to enroll 315 patients.  Instead, enrollment ...
(Date:10/20/2014)... ENGLEWOOD, Colo. , Oct. 20, 2014 /PRNewswire/ ... Inc. (NYSE MKT: AMPE), today announced that its ... the clinical and research potential for its novel ... oxidation-reduction potential (ORP) in the body in response ... clinical value of ORP as a clinical marker ...
(Date:10/20/2014)... 20, 2014   BioNano Genomics announced today achievement ... to collect human data at 30X depth, sufficient for a ... new capability was established and demonstrated for the IrysChip TM ... System and will be rolled out to BioNano,s ... be showcasing this advancement at the American Society for ...
Breaking Medicine Technology:PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3
... Inc. (NASDAQ: GMPM.PK), a marketing and product formulation company ... to retailers, both in the US and internationally, announced ... collection cycle with a major pharmacy retail chain.  Gamma ... distribution center for delivery to retail outlets in the ...
... 27, 2011 / PRNewswire/ -- Bacterin International Holdings, ... in the development of revolutionary bone graft material and anti-infective ... Russell 3000® Index after the market closed on June 24, ... Index and Russell Global Index. Annual reconstitution of ...
Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 2Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 3Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes 2Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes 3Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes 4
Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology....
Black multi-pinhole occluder...
6 inch hand held occlcuder with 49 holes...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Medicine Products: